Wuxi Biologics (2269 HK) Placement - Thought on Valuation and the Outlook
After WuXi Bio's shares experienced significant surge this year, valuation may have partially overdrawn the future growth expectations. The...
98 Views
Wuxi Biologics (2269 HK): Synthetic Expert Call Transcript (09 Oct 2026)
Geographically diversified capacity expansion is the crucial defense mechanism against geopolitical headwinds. WuXi Biologics is pivoting from...
91 Views
Aequitas: Wuxi Biologics Placement - Recent Streak of Underperforming Deals
WuXi Biologics Holdings is looking to raise US$500m from a partial selldown of its stake in Wuxi Biologics. In this note, we will talk about the...
99 Views
KTX Tactical DR Picks
We recommend opening a position in WUXI06, a DR on a biotechnology company listed on the Hong Kong stock market. Our KTX Tactical DR Port's...
95 Views
HK Strategy: Exposure to Europe - Who Are at Risk?
A recent surge in Eurozone sovereign yields will put pressure on some companies. The 100 largest HK companies have only 6% of their revenue from...
91 Views